EUVIMEDEUVIMED entdecken
Crossref

DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy

Ruobing Wang, Yanhan Liu, Yuelu Zhang, Qiuxue Yi iD, Wenjuan Xiao, Tianqin Wang, Qi Chen, Jiayang Xiang, Lu Song, Chunhong Li, Fan Li iD, Lin Liu und 4 weitere

Journal of the American Chemical Society · 05.03.2025 · 147 (9) · 7545-7554

DOI: 10.1021/jacs.4c16529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 20.02.2025. Verfasst von Ruobing Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, and Department of Ophthalmology, Renji Hospital…. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Choroidal Neovascularization, Aptamers, Nucleotide, DNA. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsChoroidal NeovascularizationAptamers, NucleotideDNABlood-Retinal BarrierAnimalsMiceVascular Endothelial Growth Factor AHumans

Substanzen

Angiogenesis InhibitorsAptamers, NucleotideVascular Endothelial Growth Factor ADNA

Autor:innen und Institutionen

  • Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, and Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127,…
  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, NHC Key laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical S…
  • School of Chemistry and Chemical Engineering, New Cornerstone Science Laboratory, Frontiers Science Center for Transformative Molecules, Zhangjiang Institute for Advanced Study, and National Center for Translational Med…

ORCID-Profile: Qiuxue Yi, Fan Li, Chunhai Fan, Xiuhai Mao, Xiaolei Zuo

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Key Research and Development Program of China
  • Innovative Research Team of High-level Local University in Shanghai
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Clinic Plus Outstanding Project of Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine

Zitieren

APA

Wang, R., Liu, Y., Zhang, Y., Yi, Q., Xiao, W., Wang, T., Chen, Q., Xiang, J., Song, L., Li, C., Li, F., Liu, L., Li, Q., Fan, C., Mao, X., & Zuo, X. (2025). DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy. Journal of the American Chemical Society, 147(9), 7545-7554. https://doi.org/10.1021/jacs.4c16529

Vancouver

Wang R, Liu Y, Zhang Y, Yi Q, Xiao W, Wang T, et al. DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy. Journal of the American Chemical Society. 2025;147(9):7545-7554. doi:10.1021/jacs.4c16529

BibTeX
@article{Wang2025,
  author = {Wang, Ruobing and Liu, Yanhan and Zhang, Yuelu and Yi, Qiuxue and Xiao, Wenjuan and Wang, Tianqin and Chen, Qi and Xiang, Jiayang and Song, Lu and Li, Chunhong and Li, Fan and Liu, Lin and Li, Qian and Fan, Chunhai and Mao, Xiuhai and Zuo, Xiaolei},
  title = {DNA Framework-Enabled Ocular Barrier Penetration for Microinvasive Antiangiogenic Therapy},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  volume = {147},
  number = {9},
  pages = {7545--7554},
  doi = {10.1021/jacs.4c16529}
}
Kostenlos starten →